There were 1,030 press releases posted in the last 24 hours and 432,258 in the last 365 days.

Global Liver Diseases Therapeutics Market to 2019 - Increased Prevalence of Liver Diseases is a Key Market Driver

Dublin, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/6rkqnx/global_liver) has announced the addition of the "Global Liver Diseases Therapeutics Market 2015-2019" report to their offering.

This report covers the present scenario and the growth prospects of the global liver diseases therapeutics market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of liver diseases.

Based on disease indication, the market is segmented as follows:

  • Non-alcoholic fatty liver disease (includes non-alcoholic steatohepatitis)
  • Liver cirrhosis
  • Liver cancer
  • Hepatitis (Hepatitis A, B, and C)

The report, Global Liver Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the global liver diseases therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

  • F. Hoffmann-La Roche
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Disease overview

PART 06: Market landscape

PART 07: Market segmentation by disease

PART 08: Global hepatitis therapeutics market

PART 09: Global liver cancer therapeutics market

PART 10: Global nonalcoholic fatty liver disease therapeutics market

PART 11: Global liver cirrhosis therapeutics market

PART 12: Market segmentation by type of molecule

PART 13: Geographical segmentation

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

PART 20: Key vendor analysis

PART 21: Appendix

For more information visit http://www.researchandmarkets.com/research/6rkqnx/global_liver



CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Healthcare and Medical Devices

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.